10 Best Prefered Stocks To Buy Right Now

It’s no secret that Microsoft (NASDAQ: MSFT  ) has missed or bungled its fair share of opportunities over the last decade, and it shows. Excluding dividends, the lumbering tech giant’s shares have been flat for the better part of a decade — until recently.

Despite its many detractors, Microsoft’s stock has been on a tear in 2013, having risen around 30%. And while it was fair to stay that Microsoft was simply too cheap, that’s not necessarily the case anymore. In the video below, Fool contributor Andrew Tonner investigates whether there’s still opportunity in Microsoft shares today.

It’s been a frustrating path for Microsoft investors, who’ve watched the company fail to capitalize on the incredible growth in mobile over the past decade. However, with the release of its own tablet, along with the widely anticipated Windows 8 operating system, the company is looking to make a splash in this booming market. In a new premium report on Microsoft, a Motley Fool analyst explains that while the opportunity is huge, so are the challenges. The report includes regular updates as key events occur, so make sure to claim a copy of this report now by clicking here.

10 Best Prefered Stocks To Buy Right Now: United Utilities Group PLC (UUGRY)

United Utilities Group PLC, incorporated on April 08, 2008, is the holding company of a group which owns and operates water and wastewater assets in the North West of England. The Company provides water and wastewater services to around seven million people and businesses in the North West of England, through its wholly owned subsidiary United Utilities Water PLC (UUW). UUW holds licenses to provide water and wastewater services to a population of approximately seven million people in the North West of England.

The Company had approximately 56,000 hectares of catchment land, approximately 189 reservoirs, approximately 94 water treatment works, over 42,000 kilometers of water pipes, over 77,000 kilometers of sewer pipes, and approximately 570 wastewater treatment works. The Company’s wholly owned subsidiaries include United Utilities Water PLC and United Utilities Property Services Limited.

Advisors’ Opinion:

  • [By G. A. Chester]

    Imperial Tobacco (LSE: IMT  ) (NASDAQOTH: ITYBY  ) , British Sky Broadcasting (LSE: BSY  ) , and United Utilities (LSE: UU  ) (NASDAQOTH: UUGRY  ) are three companies from the U.K.’s elite FTSE 100 index that have grown both their earnings and dividends faster than inflation — and are forecast to continue doing so.

  • [By Harvey Jones]

    Severn Trent’s share price has had a flat 12 months, aside from a bout of takeover excitement in May, which pushed the stock to a 12-month high of 20.90p. But management rejected the bid, claiming it failed to recognize the value in the business, and the excitement trickled away. Now it trades at 7.20p. That still represents of rise of 23% over three years and 29% over five years, against 18% and 26% for the FTSE 100 respectively. So there is growth to be had, although being a utility, most investors will focus on the income. Right now, Severn Trent yields 4.41%. That is less than fellow water company United Utilities Group (UUGRY), which yields 5.05%, but still comfortably above the FTSE 100 average of 3.54%.

10 Best Prefered Stocks To Buy Right Now: Novartis AG (NVS)

Novartis AG, incorporated on February 29, 1996, provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Its portfolio includes medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. The Company has five segments: Pharmaceuticals, which include patent-protected prescription medicines; Alcon, which include surgical, ophthalmic pharmaceutical and vision care products; Sandoz, which include generic pharmaceuticals; vaccines and diagnostics, which include human vaccines and blood-testing diagnostics, and consumer health, which include over-the-counter medicines (OTC) and Animal Health. On April 8, 2011, the Company acquired the remaining non-controlling interest in Alcon, Inc. In December 2013, Alliance Pharma plc announced that its wholl y owned subsidiary, Alliance Pharmaceuticals Limited, acquired all the United Kingdom and Republic of Ireland (ROI) rights to Lypsyl from Novartis AG.

In April 2011, Novartis sells global rights to Elidel, a medicine to treat atopic dermatitis to Meda. In March 2011, Novartis completes acquisition of majority stake in Zhejiang Tianyuan vaccines company in China. In March 2011, the Company acquired Genoptix, Inc. In October 2011, Novartis discontinues development of AGO178 for depressive disorder. In December 2011, the Company discontinues development of PRT128 for acute coronary syndrome and chronic coronary heart disease, and SMC021 for osteoporosis and osteoarthritis. In April 2011, Alcon’s portfolio of generic ophthalmic medicines sold through its Falcon business unit primarily in the United States.

Pharmaceuticals Division

The Company’s Pharmaceuticals Division researches, develops, manufactures, distributes and sells patented pr escription medicines in the therapeutic areas, such as Oncol! ogy; Primary Care, consisting of Primary Care medicines and Established Medicines, and Specialty Care, consisting of Ophthalmology, Neuroscience, Integrated Hospital Care, and Critical Care medicines. The Pharmaceuticals Division is organized into global business franchises responsible for the commercialization of various products, as well as Novartis Oncology, a business unit responsible for the global development and commercialization of oncology products, and Novartis Molecular Diagnostics, a business responsible for the development and commercialization of diagnostic tests and services related to its pharmaceuticals portfolio and therapeutic areas.

The Company’s Oncology products include Afinitor/Votubia, Exjade, Sandostatin SC/Sandostatin LAR , Femara , Zometa, Tasigna and Gleevec/Glivec. Gleevec/Glivec, which is a signal transduction inhibitor approved to treat patients with certain forms of chronic myeloid leukemia (CML) and gastrointestinal stromal tu mors (GIST). Tasigna is a signal transduction inhibitor of the tyrosine kinase activity of Bcr-Abl, KIT+ and the PDGF-receptor. Zometa is a treatment to reduce or delay skeletal-related events (SREs), including pathologic fracture, spinal cord compression, and/or requirement of radiation therapy or surgery to bone, in patients with bone metastases (cancer that has spread to the bones) from solid tumors and multiple myeloma. Femara is a once-daily oral aromatase inhibitor for the treatment of early stage or advanced breast cancer in postmenopausal women. Sandostatin SC/Sandostatin LAR is indicated for the treatment of patients with acromegaly, a chronic disease caused by over-secretion of pituitary growth hormone in adults. Sandostatin is also indicated for the treatment of patients with certain symptoms associated with carcinoid tumors and other types of gastrointestinal and pancreatic neuroendocrine tumors. Exjade is an oral iron chelator approved for the treatment of chron ic iron overload due to blood transfusions in patients over ! two years! of age who have a range of underlying anemias. Patients with congenital and acquired chronic anemia, such as thalassemia, sickle cell disease and myelodysplastic syndromes, require transfusions, which puts them at risk of iron overload. Afinitor/Votubia is an oral inhibitor of the mTOR pathway.

The Company’s Primary Care products include Arcapta Neohaler/Onbrez Breezhaler, Diovan, Exforge, Tekturna/Rasilez, Galvus, Reclast/Aclasta, Voltaren/Cataflam, Ritalin, Ritalin LA, Focalin and Focalin XR. Its Specialty Care products include Lucentis, Gilenya, Exelon, Extavia and Comtan, and Stalevo. Its Integrated Hospital Care include Zortress/Certican, Ilaris, Neoral and Myfortic.The Company’s Critical Care products include Xolair and Tobi Podhaler. As of December 31, 2011, the products under development includes ACZ885, which is being investigated for the secondary prevention of cardiovascular events and for the treatment of Diabetes Mellitus; AEB071 (sotrastaurin) is a low molecular weight, selective inhibitor of protein kinase-C (PKC); AFQ056 (mavoglurant) is a metabotropic glutamate receptor 5 (mGluR5) antagonist in Phase II development for the treatment of Parkinson’s disease levodopa-induced dyskinesia; AIN457 (secukinumab) is a human monoclonal antibody neutralizing interleukin-17A, a key pro-inflammatory cytokine expressed by TH17 cells and other types of white blood cells; BAF312 is an oral, second-generation sphingosine 1-phosphate receptor modulator in Phase II development for relapsing-remitting multiple sclerosis; DEB025 (alisporivir) is a cyclophilin inhibitor for the treatment of Hepatitis C virus infection (HCV); Gileny a line treatment for relapsing forms of MS; Exjade (deferasirox) is an oral iron chelator in development for use in patients with non-transfusion-dependent thalassemia (NTDT); INC424 (ruxolitinib) is an investigational Janus kinase (JAK) inhibitor, and Zortress/Certican (everolimus) is an mTOR inhibitor with immune/non-immune cell proliferation inhibition being d! eveloped ! for prevention of solid organ transplant rejection.

Alcon Division

The Company’s Alcon Division discovers, develops, manufactures, distributes and sells eye care products. Alcon is engaged in eye care with product offerings in Surgical, Ophthalmic Pharmaceuticals and Vision Care. In Surgical, Alcon develops, manufactures, distributes and sells ophthalmic surgical equipment, instruments, disposable products and intraocular lenses. In Pharmaceutical, Alcon discovers, develops, manufactures, distributes and sells medicines to treat chronic and acute diseases of the eye, as well as over-the-counter medicines for the eye. In Vision Care, Alcon develops, manufactures, distributes and sells contact lenses and lens care products.

Alcon’s Surgical portfolio includes the Infiniti vision system for cataract procedures, the Constellation vision system for retinal operations, and the AcrySof family of intraocular lenses (IOLs), including the AcryS of IQ, AcrySof IQ ReSTOR, AcrySof IQ Toric and AcrySof IQ ReSTOR Toric IOLs. During the year ended December 31, 2011, its Alcon Division launched the LenSx femtosecond laser, a technology in cataract surgery, which increases the precision and reproductibility for corneal incisions, capsulorhexis and lens fragmentation steps of the procedure. In addition, Alcon provides advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery.

Alcon Division’s Ophthalmic Pharmaceuticals business combines Alcon’s range of pharmaceuticals with selected ophthalmic products (excluding Lucentis) previously marketed by the Novartis Pharmaceuticals Division. The products treat chronic and acute diseases of the eye including glaucoma and allergies, as well as anti-infective/anti-inflammatory and dry eye treatments. our Alcon Division’s Ophthalmic Pharmaceuticals portfolio include Travatan Z solution and DuoTrav soluti on for the treatment of elevated intraocular pressure associ! ated with! glaucoma; Vigamox solution for bacterial conjunctivitis; Pataday solution for ocular itching associated with allergic conjunctivitis; and Nevanac suspension for eye inflammation following cataract surgery. Alcon launched a number of products during 2011, including Dailies Total 1 lenses, Opti-Free EverMoist Multi Purpose Disinfecting Solution, LenSx laser, AcrySof IQ ReSTOR Toric lens, AcrySof IQ Toric T6-T9 lens, Travatan BAK-free solution, DuoTrav BAK-free solution, Moxeza solution and Systane Balance eye drops.

Sandoz Division

The Company’s Sandoz Division is a global generic pharmaceuticals company that develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical and biotechnological active substances, which are not protected by valid and enforceable third-party patents. The Sandoz Division has activities in Retail Generics, Anti-Infectives, and Biopharmaceuticals and Oncology Injectables. In Retail Generics , Sandoz develops, manufactures and markets active ingredients and finished dosage forms of pharmaceuticals, as well as supplying active ingredients to third parties. In Anti-Infectives, Sandoz develops and manufactures active pharmaceutical ingredients and intermediates, mainly antibiotics, for internal use by retail generics and for sale to third-party customers. In Biopharmaceuticals, Sandoz develops, manufactures and markets protein- or other biotechnology-based products (biosimilars or follow-on biologics) and sells biotech manufacturing services to other companies.

In Oncology Injectables, Sandoz develops, manufactures and markets primarily cytotoxic products for the hospital market. During 2011, the Company launched generic docetaxel (Taxotere), higher-strength generic amlodipine-benazepril (Lotrel), generic meropenem (Merem) injection, and the formation of a women’s health portfolio with generic Seasonale, Nordette, Yaz and Yasmin. The product launched in various European countries included generic docetaxel, ge! neric ana! strazole (Arimidex), and valsartan/covalsartan (an early entry generic version of Novartis Pharmaceuticals’ Diovan/Co-Diovan).

Vaccines and Diagnostics Division

The Company’s Vaccines and Diagnostics Division researches, develops, manufactures, distributes and sells preventive vaccines and diagnostic tools. Novartis Vaccines is a global developer and manufacturer of human vaccines. Novartis Diagnostics is a blood testing and molecular diagnostics business dedicated to preventing the spread of infectious diseases through blood-screening tools that protect the world’s blood supply. Novartis Vaccines’ products include influenza, meningococcal, pediatric, adult and travel vaccines.

The Company’s influenza vaccines include Agrippal, Fluad, Fluvirin and Optaflu. Its Meningococcal Vaccines includes Menjugate and Menveo. Its travel vaccines include Encepur Children, Encepur Adults, Ixiaro and Rabipur/Rabavert. Its Pediatric Vaccines includ e Polioral and Quinvaxem.

Consumer Health

Consumer Health consists of two Divisions: OTC (over-the-counter medicines) and Animal Health. Each has its own research, development, manufacturing, distribution and selling capabilities. OTC offers readily available consumer medicine. Animal Health provides veterinary products for farm and companion animals.

OTC (over-the-counter medicines) offers products for the treatment and prevention of common medical conditions and ailments. OTC business focuses on a group of global brands in product categories that include treatments for cough/cold/respiratory (Triaminic, Otrivin, TheraFlu/NeoCitran), pain relief (Excedrin, Voltaren), digestive health (Benefiber, Prevacid24HR, Pantoloc Control), dermatology (Lamisil, Fenistil), and smoking cessation (Habitrol/Nicotinell).

Animal Health offers products and services focusing on both companion and farm animals (including cultivated fish). Key products for c ompanion animals include Atopica (atopic dermatitis manageme! nt), Dera! maxx and Onsior (pain relief), Fortekor (heart failure in dogs, chronic renal insufficiency in cats), and Sentinel/Milbemax/Interceptor (intestinal parasite control and heartworm prevention), while farm animal products include the therapeutic anti-infective Denagard, an antimicrobial used to treat and control bacteria in swine, CLiK, an insect growth regulator used to control blowfly strike in sheep, cattle vaccines used to prevent respiratory and reproductive diseases in beef and dairy cattle, and Zolvix, a sheep drench representing the new sheep anthelmintic class. Aquaculture products include vaccines and treatments mainly used in salmon farming.

Advisors’ Opinion:

  • [By Sara Sjolin]

    The benchmark was lifted by a solid gain for Novartis AG (CH:NOVN)   (NVS) , up 3% after the drug maker said it will close its trial of a heart-failure drug early because of the strength of the results so far.

  • [By MONEYMORNING.COM]

    Almirall S.A. has helped develop the drug in Mexico and parts of Europe. A unit of Novartis AG (NYSE: NVS) is concentrating on parts of the Middle East, Africa, and Asia. And Bayer AG (OTC: BAYRY) has provided key support in Sativex’s development in the UK and Canada.

  • [By Jayson Derrick]

    Novartis’ (NYSE: NVS) Jakavi treatment has achieved its main goal in a Phase III trial of maintaining red-blood cell volume in patients with polycythemia vera, a deadly form of cancer. Shares lost 0.81 percent, closing at $83.14.

  • [By Patricio Kehoe]

    Johnson & Johnson (JNJ) comes in next, the fund owning over 235,000 shares, worth $21.5 million. The company operates in a highly competitive industry, including companies such as Novartis AG (NVS) and Pfizer Inc. (PFE). The company reported earnings per share increased by 32.5% compared to the same quarter one year prior, and has demonstrated a pattern of positive earnings per share growth over the past two years. The company returns cash to investors, and its current dividend yield is 2.83%, which is considered quite enough to protect the purchasing power.

10 Best Prefered Stocks To Buy Right Now: Mackinac Financial Corporation(MFNC)

Mackinac Financial Corporation operates as the holding company for mBank that engages in commercial banking business. It offers interest bearing and non-interest bearing deposit products, including commercial and retail checking accounts, negotiable order of withdrawal accounts, money market accounts, individual retirement accounts, regular interest-bearing statement savings accounts, and certificates of deposit. The company?s loan portfolio comprises commercial real estate loans; commercial, financial, and agricultural loans; one-to-four family residential real estate loans; construction loans; and consumer loans. It operates 6 branch offices in the Upper Peninsula of Michigan, and 4 branch offices in Michigan?s Lower Peninsula; and also operates 10 automated teller machines. The company was founded in 1974 and is headquartered in Manistique, Michigan.

Advisors’ Opinion:

  • [By Marc Bastow]

    Michigan-based bank holding company Mackinac Financial (MFNC) raised its quarterly dividend 25% to 5 cents per share, payable on Jan. 8 to shareholders of record as of Dec. 30.
    MFNC Dividend Yield: 2.1%

10 Best Prefered Stocks To Buy Right Now: ParkerVision Inc.(PRKR)

Parkervision, Inc. engages in the design, development, and sale of proprietary radio frequency (RF) technologies and products for use in semiconductor circuits for wireless communication products in the United States. The company provides its wireless technologies for processing RF waveforms in wireless applications. Its technology applies to transmit and receive functions of a radio transceiver. Its transmit portion of the technology, Direct2Power, enables the transformation of a baseband data signal to an RF carrier waveform at the desired power output level in a single unified operation. The company?s receiver portion of the technology, Direct2Data, enables the direct conversion of an RF carrier to a baseband data signal. It also provides engineering consulting and design services to its customers to assist them in developing prototypes and/or products incorporating its technologies. The company licenses its intellectual property and sells integrated circuits for incor poration into wireless devices designed by its customers. It primarily focuses on incorporating its technologies into mobile handsets, as well as to other wireless products that are related to networks serving mobile handsets, such as data cards, femtocells, and machine-to-machine and embedded applications. The company?s technology is also used in non-cellular radio applications comprising military radios. In addition, Parkervision, Inc. develops wireless radio modules for mobile handset and data card applications through a joint development and marketing agreement with LG Innotek Co., Ltd. It serves mobile handset manufacturers and their chipset suppliers in the mobile handset industry. The company was founded in 1989 and is headquartered in Jacksonville, Florida.

Advisors’ Opinion:

  • [By Roberto Pedone]

    One under-$10 technology player that’s quickly moving within range of triggering a major breakout trade is ParkerVision (PRKR), which designs, develops and markets its proprietary radio frequency technologies and products for use in semiconductor circuits for wireless communication products. This stock has been red hot so far in 2013, with shares up sharply by 105%.

    If you take a look at the chart for ParkerVision, you’ll notice that this stock has been uptrending strong for the last month, with shares soaring higher from its low of $2.38 to its recent high of $4.29 a share. During that uptrend, shares of PRKR have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed share of PRKR back above both its 50-day and 200-day moving averages. Shares of PRKR have now moved within range of triggering a major breakout trade.

    Traders should now look for long-biased trades in PRKR if it manages to break out above some near-term overhead resistance at $4.29 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 2.51 million shares. If that breakout triggers soon, then PRKR will set up to re-fill some of its previous gap down zone from late October that started at $7.50 a share. Some possible upside targets if PRKR gets into that gap down zone with volume are $5 to $6 a share.

    Traders can look to buy PRKR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day moving average of $3.90 a share, or near its 50-day moving average of $3.56 a share. One can also buy PRKR off strength once it takes out $4.29 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By Bryan Murphy]

    I hate to be the one to say I told you so, but, I told you so. It’s Vringo, Inc. (NASDAQ:VRNG) all over again. What’s that? The euphoria – the certainty – that drove ParkerVision, Inc. (NASDAQ:PRKR)  shares from a price of $2.46 to a high of $7.78 in just seven trading days, only to see it all come crashing down on the 8th day. PRKR plunged to a close of $2.90 on the 8th day (yesterday) when the gamble didn’t pan out for speculators who were sure it would. Score another one for not picking stocks like you were tossing a coin.

  • [By Paul Ausick]

    Stocks on the Move: ParkerVision Inc. (NASDAQ: PRKR) is down 59.2% at $2.89 following a smaller-than-hoped-for award in its patent suit against Qualcomm Inc. (NASDAQ: QCOM). NQ Mobile Inc. (NYSE: NQ) is down 50.7% at $11.28 following a blistering from analysts at Muddy Waters.

  • [By Bryan Murphy]

    I don’t come hear to pat myself on the back, however. I come hear to let you know the same conditions that made American Community overbought and ripe for a reversal and suggested Real Goods Solar, Inc. was ready to rally are now saying – respectively – ParkerVision, Inc. (NASDAQ:PRKR) shares are due for a pullback and Arca Biopharma Inc. (NASDAQ:ABIO) is on the verge of a big bullish thrust.

10 Best Prefered Stocks To Buy Right Now: Tesco PLC (TSCDY)

Tesco PLC, incorporated on November 27, 1947, is engaged in retailing and associated activities in the United Kingdom, China, the Czech Republic, Hungary, the Republic of Ireland, India, Malaysia, Poland, Slovakia, South Korea, Thailand and Turkey. The Company also provides retail banking and insurance services through its subsidiary, Tesco Bank. The Company’s operations in the United Kingdom is the within the Company, with over 3,000 stores. The Company’s in-store picking model is complemented by a small number of specialized dotcom-only stores, which allow the Company to respond to customer demand. The Company’s Click & Collect service is a part of its multichannel offering and enables customers to pick up their shopping when and where it suits them. It has over 1,500 Click & Collect collection points for general merchandise and over 150 Grocery Drive-thrus in the United Kingdom.

The Company’s operations in India include sourcing and its service cent re, as well as a franchise arrangement with Tata Group. The Company’s Hindustan Service Centre (HSC) is the global services arm for Tesco worldwide, providing business services for Tesco operations globally. Tesco HSC is engaged in creating and executing strategic initiatives covering information technology (IT), Financial, Commercial and Property, among others. The Company also provides 80% of the stock sold by Star Bazaar, both food and non-food, sourced through its distribution centre in Mumbai. This distribution centre also provides wholesale products to traditional Indian retailers, kirana stores, restaurants and other businesses, providing small farmers and other suppliers with a way to sell their wares to the local market.

The Company has an online business and 22 of virtual stores in South Korean subways and bus stops, which help time-pressed customers, shop on-the-go using their smartphones. Tesco Lotus is its international business, serving over 11 m illion customers every week in over 1,400 stores. Tesco Bank! offer a range of simple personal banking products, principally-mortgages, credit cards, personal loans, and savings.

Advisors’ Opinion:

  • [By Sally Jones]

    According to the GuruFocus Value Screen for finding historical lows, two food retailers Empire Company Limited (TSX:EMP.A) and Tesco PLC (TSCDY), and a farm and ranch retailer, Tractor Supply (TSCO) are held by guru investors and are being traded at or near a 10-year low.  Here are the company updates and trading highlights as of the third quarter of 2013.

  • [By G. A. Chester]

    LONDON — Top British supermarket Tesco  (LSE: TSCO  ) (NASDAQOTH: TSCDY  ) is due to announce its annual results on April 17.

  • [By Alan Oscroft]

    Tesco
    Next Wednesday, April 17, brings us one of the most hotly awaited company announcements of 2013 so far — full-year results from Tesco  (LSE: TSCO  ) . (NASDAQOTH: TSCDY  ) After the U.K.’s biggest supermarket had a weak Christmas in 2011, and saw its share price slump as a result, Warren Buffett famously bought in big. And he’s done well so far — from a 52-week low of 295 pence back in June last year, Tesco shares are now back up 30%, to 385 pence.

10 Best Prefered Stocks To Buy Right Now: Green Technology Solutions Inc (GTSO)

Green Technology Solutions Inc (GTSO), incorporated on February 22, 1991, is in the business of identifying and acquiring rights in early stage, green technologies, with the plan to develop these technologies into marketable products. The Company has identified several technology endeavors.

As of December 31, 2011, the Company has identified the advancement of mining technologies, with an emphasis on rare earth and precious metals mining applications, the development of additional markets for existing paint products that are being marketed in the United States, and smart grid technology. GTSO has also identified additional joint venture in China and South America.

Advisors’ Opinion:

  • [By CRWE]

    Today, GTSO has shed (-5.66%) down -0.0018 at $.0300 with 22,150 shares in play thus far (ref. google finance Delayed: 11:34AM EDT July 3, 2013), but don’t let this get you down.

    Previously after forging a new joint venture, Green Technology Solutions, Inc. and Chilerecicla are already hard at work identifying new Latin American companies and locales ideally suited to the partnership’s ambitious expansion plans.

    The partnership has targeted Latin America for expansion because it’s a key emerging market in the booming global e-waste recycling and reuse services industry, which Transparency Market Research predicts accounted for more than $9 billion in 2012. The firm expects the worldwide e-waste market to reach $18 billion in 2017, growing at a compound annual growth rate of 13.2 percent from 2012 to 2017.

  • [By CRWE]

    Today, GTSO surged (+0.32%) up +0.0001 at $.0309 with 12,300 shares in movement thus far (ref. google finance Delayed: 10:31AM EDT June 20, 2013).

    Green Technology Solutions, Inc. previously reported it has finalized a joint venture agreement with leading Latin American e-waste recycler Chilerecicla.

    Latin America is a key emerging market in the booming the global e-waste recycling and reuse services industry, which Transparency Market Research predicts accounted for more than $9 billion in 2012. The firm expects the worldwide e-waste market to reach $18 billion in 2017, growing at a compound annual growth rate of 13.2 percent from 2012 to 2017.

10 Best Prefered Stocks To Buy Right Now: MFA Financial Inc (MFA)

MFA Financial, Inc., incorporated on July 24, 1997, is engaged in the business of investing, on a leveraged basis, in residential Agency mortgage-backed securities (MBS) and Non-Agency MBS. Its business objective is to generate net income for distribution to its stockholders resulting from the difference between the interest and other income it earn on its investments and the interest expense it pays on the borrowings, which it uses to finance its leveraged investments and its operating costs. Its operating policies require that at least 50% of its investment portfolio consist of ARM-MBS, which are either Agency MBS or rated in two rating categories by at least one of rating agency, such as Moody’s Investors Services, Inc., Standard & Poor’s Corporation (S&P) or Fitch, Inc. The remainder of its assets may consist of direct or indirect investments in other types of MBS and residential mortgage loans; other mortgage and real estate-related debt and equity; and other yiel d instruments.

The mortgages collateralizing the Company’s MBS portfolio are Hybrids, ARMs and 15-year fixed-rate mortgages. The Hybrids collateralizing its MBS typically have fixed-rate periods ranging from three to 10 years. Interest rates on the mortgage loans collateralizing its ARM-MBS reset based on specific index rates, which include London Interbank Offered Rate (LIBOR) or the one-year constant maturity treasury (CMT) rate. The mortgages collateralizing its ARM-MBS have interim and lifetime caps on interest rate adjustments. The Company’s Non-Agency MBS have been at discounts to face/par value.

Advisors’ Opinion:

  • [By Dan Burrows]

    SAN stock also has some nice momentum early in the second quarter, breaking above both its 50- and 200-day moving averages.

    Cheap Dividend Stocks #5: MFA Financial (MFA)

    Share Price as of 4/4: $7.78
    YTD Stock Performance: 10%
    Dividend Yield: 10.4%

  • [By Rich Duprey]

    After raising its payout last quarter by 10%, residential mortgage-backed securities REIT MFA Financial (NYSE: MFA  ) announced today it was keeping its second-quarter dividend steady at $0.22 per share.

  • [By Jonas Elmerraji]

    We’re seeing the exact opposite setup in shares of MFA Financial (MFA). Unlike NCT, shares of MFA have been in a well-defined downtrend since the middle of May. That high probability range puts this stock’s likely target price lower for the end of August.

    Since the best time to buy an uptrend is at support, it makes sense that the best time to sell a stock in a downtrend is at trendline resistance. That’s the exact level that MFA is testing this week. If you own MFA right now, it makes sense to be a seller on the first semblance of a bounce lower.

    Momentum provides some extra confirmation here too. RSI has been suck down in bearish territory since the uptrend began in May. Oscillators like RSI tend to become range-bound when stocks’ price action trends. I’d look for a move above 50 on RSI as a precondition to a move higher in price.

10 Best Prefered Stocks To Buy Right Now: Nam Tai Electronics Inc.(NTE)

Nam Tai Electronics, Inc. provides electronics manufacturing and design services to the original equipment manufacturers of telecommunication and consumer electronic products. The company?s Consumer Electronic and Communication Products segment manufactures mobile phone accessories, such as headsets containing Bluetooth wireless technology, and phone cradles, as well as snap-on portable music speaker, FM radio adaptors, and GPS adaptors; entertainment devices, including USB Web cam for interactive games, USB microphone and converter box Karaoke, and buzzer devices for quiz games; educational products consisting of digital pens, calculators, and electronic dictionaries; and optical devices comprising CMOS imaging sensor modules for notebook computers, portable media players, and recording cameras for the automotive industry. Its Telecommunication Component Assembly segment offers subassemblies and components, such as color and monochrome LCD modules for PDA phones, smart p hones, mobile phones, and telephone systems; RF modules for integration into mobile phones; DAB modules for digital radio products, including home tuners, kitchen radios, in-car receivers, CD players, clock radios, boom boxes, midi-systems, and handheld portable devices; FPC subassemblies for LCD modules and electronic devices; FPC boards for mobile phones, PDAs, office automation, and laptop computers; front and back light panels for handheld video game devices; and high-frequency cordless telephones and home feature phones. The company?s LCD Products segment manufactures LCD panels for watches and medical instruments, white goods and industrial applications, automotive parts and appliances, car audio systems, hand held products, VoIP phones, and office automation applications. It sells its products to customers in Hong Kong, North America, Europe, Japan, the People?s Republic of China, and Korea. The company was founded in 1975 and is headquartered in Shenzhen, the Peopl e ?s Republic of China.

Advisors’ Opinion:

  • [By Evan Niu, CFA]

    What: Shares of Nam Tai Electronics (NYSE: NTE  ) got crushed today by as much as 37% after the company reported earnings.

    So what: Revenue in the first quarter more than doubled to $177.5 million, which translated into earnings per share of $0.11. Both figures handily topped consensus estimates, which were calling for $150 million in sales and $0.05 per share in profit. The real cause for concern was within Nam Tai’s guidance.

  • [By Rick Munarriz]

    Nam Tai Electronics  (NYSE: NTE  ) — $6.78
    Shares of Nam Tai took a hit three months ago after posting uninspiring quarterly results.

10 Best Prefered Stocks To Buy Right Now: Le Gaga Holdings Limited (GAGA)

Le Gaga Holdings Limited engages in cultivating, processing, and distributing vegetables, fruits, and tea leaves in the People’s Republic of China and Hong Kong. The company is also involved in cultivating and selling fir trees. It offers solanaceous vegetables, including sweet peppers, tomatoes, eggplants, pumpkins, and cucumbers; leafy vegetables comprising flowering Chinese cabbage, baby bok choy, and baby Chinese cabbage; and cruciferous vegetables, such as broccoli and Chinese cabbage. As of March 31, 2012, the company operated 11 farms with an aggregate area of 1,671 hectares in Fujian, Guangdong, and Hebei provinces. It sells approximately 50 varieties of vegetables primarily to wholesalers, institutional customers, and supermarket chains. The company was founded in 2004 and is based in Kowloon, Hong Kong.

Advisors’ Opinion:

  • [By Monica Gerson]

    Le Gaga Holdings (NASDAQ: GAGA) is estimated to report its Q4 earnings.

    Adobe Systems (NASDAQ: ADBE) is expected to post its Q3 earnings at $0.34 per share on revenue of $1.01 billion.

10 Best Prefered Stocks To Buy Right Now: STAG Industrial Inc (STAG)

STAG Industrial, Inc., incorporated on July 21, 2010, is an integrated, full-service real estate company focused on the acquisition, ownership and management of single-tenant industrial properties throughout the United States. As of December 31, 2012, the Company owned 172 properties in 31 states with approximately 29.4 million rentable square feet, consisting of 112 warehouse/distribution properties, 39 light manufacturing properties and 21 flex/office properties. As of December 31, 2012, its properties were 95.1% leased to 156 tenants, with no single tenant accounting for more than 2.7% of its total annualized rent and no single industry accounting for more than 10.7% of its total annualized rent. In January 2014, the Company announced that it has completed the acquisition of six buildings, consisting of two light manufacturing facilities and four warehouse and distribution facilities.

Its ability to re-lease space subject to expiring leases will impact its results of operations and is affected by economic and competitive conditions in its markets and by the desirability of its individual properties. As of December 31, 2012, it had approximately 1.4 million rentable square feet of available space in its properties. For the year ended December 31, 2012, it has achieved an 84% tenant retention rate for those tenants whose leases were scheduled to expire in 2012.Its rental expenses generally consist of utilities, real estate taxes, management fees, insurance and site repair and maintenance costs. For the majority of its tenants, its rental expenses are controlled, in part, by the triple net provisions in tenant leases. In its triple net leases, the tenant is responsible for all aspects of and costs related to the property and its operation during the lease term, including utilities, taxes, insurance and maintenance costs. Real estate investments are carried at cost less accumulated depreciation and amortization. The cost of real estate includes the purchase price of the property and lease! hold improvements. Total revenue consists primarily of rental income from its properties, lease termination fees, tenant reimbursements for insurance, real estate taxes and certain other expenses, and asset management fees. As of December 31, 2012 and December 31 2011, there were two and three vacant properties, respectively, owned by STAG Investments III, LLC (Fund III) and not contributed to the Company in the Formation Transactions (the Option Properties).

The Company evaluates the carrying value of all tangible and intangible real estate assets held for use for possible impairment when an event or change in circumstance has occurred that indicates their carrying value may not be recoverable. STAG Investments IV, LLC and STAG GI Investments, LLC (which are certain of the Participants and are referred to as part of the STAG Contribution Group), contributed 100% of their real estate entities and operations in exchange for 7,320,610 Common Units. On April 18, 20 12, the Company entered into an agreement with affiliates of Columbus Nova Real Estate Acquisition Group, Inc. (Columbus Nova) to source sale leaseback transactions for potential acquisitions by the Company. On June 15, 2012, the Company acquired six industrial properties representing approximately 750,000 square feet in total for an aggregate purchase price of approximately $30.0 million directly from Columbus Nova. At the June 15, 2012 acquisition of these six industrial properties, the Company paid Columbus Nova an acquisition fee in the form of 15,789 Common Units. On December 22, 2011, the Company sold a vacant flex/office property located in Amesbury, MA containing approximately 78,000 net rentable square feet. On April 20, 2012, the Company sold a vacant warehouse and distribution facility located in Youngstown, OH containing 153,708 net rentable square feet. On November 30, 2012, the Company sold the Great Bend, KS building.

Advisors’ Opinion:

  • [By Marc Bastow]

    Single-tenent industrial properties real estate investment trust (REIT) Stag Industrial (STAG) raised its annual dividend 5% to $1.26 per share. The first monthly payment is payable on Feb. 17 to shareholders of record as of Jan. 31.
    STAG Dividend Yield: 6.4%

  • [By Brad Thomas]

    Other REITs mentioned: (O), (NNN), (STAG), (DCT), (EGP), (PDM), (DRE), (LRY)

    Source: Chambers Street: More Liquidity Magic On The Way In REIT-Dom

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More…)

  • [By Rich Duprey]

    Industrial real estate investment trust STAG Industrial  (NYSE: STAG  ) yesterday announced its second-quarter dividend, the eighth consecutive quarterly payout it’s made.

  • [By Rich Duprey]

    Single-tenant industrial REIT STAG Industrial  (NYSE: STAG  ) announced today its third-quarter dividend of $0.30 per share, the same rate it’s paid for the past two quarters after raising the payout 11% from $0.27 per share.